Final Announcement for Global Pharmacovigilance 2019

13th Global Pharmacovigilance and clinical trials summit
March 28-29, 2019
Osaka, Japan

Dear 

It is an honor for us to invite you as a speaker/Delegate at Global Pharmacovigilance 2019 which is scheduled to be held in the month of March 28-29, in the magnificent city of Osaka, Japan. The conference will feature interactive get together of researchers, scientists, students and entrepreneurs illuminating the facts and recent researches in the sward of Pharmacovigilance.

Our confirmed Speakers:

Dr. Jacob Joseph, Harward Medical School, USA

Dr.Ujwala Salvi, Nucleon Therapeutics, India

Mr. Chi Chen, E&Y, China 

Dr. Meenal Patwardhan, AbbVie, USA

Mr. Rajiv Joshi, E&Y, India

Dr. Essam, Celyad llc, Belgium

Dr. Carole, Sun Pharma, Japan

Mr. Robert, Accenture, Spain

Mr. Ravish Kumar, Salzman Group, Australia

Dr. Abdeen, Ministry of health, UK.

Dr. Ripal Gharia, Cliantha research, India

Mr. Mohammed Gayoor khan, NFPS, Malaysia

Dr. lorelei, Vice President, Pepgen Corporation, USA

Dr. Muhammed Waser Anwar, Evolet Healthcare Pvt Limited,India.

Dr. Jean Wright, Abbvie, USA.

The honor of your noble presence will adorn the conference.

We look forward to your presence. Kindly do reply to us about your interest.

Have a Good Day.
Regards,
Zoey Williams | Program Manager

                                      Plan your trip to Osaka, Japan

Theme: Promulgating the prevention of adverse drug reaction

The conference offers richer experiences for Exhibitors, Sponsors, Plenary Sessions, keynote talks, Poster presentations, B2B meetings, and networking panels.
For Conference details, please visit: https://bit.ly/2HwRNwR

Benefits

·         Best platform to develop new partnership & collaborations.

·         Network development with both Academia and Business.

·         Recognition to your products and services in the world market through our website.

·         Shape and raise your corporate image through logo branding.

·         Special privileges on group registrations.

·         Develop new client relationships and strengthen the existing ones (B2B Meeting).

Participating Companies:

·         Abbvie,USA

·         E&Y, China

·         Salmanz Group, Australia

·         Nucleon Therapetics, India

·         Saudi Patient safety Center, Saudi

·         AlphaBeta Pharma, UK

·         King Abdullah Medical City (KAMC)

·         Takeda, USA

Please let me know your confirmation at the earliest convenience.

Best Regards   Zoey A Williams| Program Coordinator   Global Pharmacovigilance 2019   Ph: 4896666555 Ext:6028   Email:  globalpharmocovigilance2019@gmail.com

Mid Term Announcement of the conference- GPV 2019

Greetings of the day!!

We heartily welcome all the participants throughout the globe to participate in the conference titled 13th Global Pharmacovigilance and clinical trials summit. This event would be a great opportunity to gather knowledge as well as experience in the field of pharmacovigilance and clinical trials.

Session of the conference:

Pre-Clinical and Clinical Trials

Adverse Drug Reactions

Good Pharmacovigilance Practice

Drug Safety

Clinical Trial Protocols

Diversity in Industrial Clinical Trials and Clinical Research

Clinical Research and Statistics

Clinical Database Management

Medical and Clinical Case Reports

Hospital and Industrial Pharmacy

Clinical Data Management and Analytics

Clinical Trial Site Selection and Management

Medical and Clinical Case Reports

Biopharmaceutical Sciences

Our Confirmed Speakers:

Keynote:(Day 1)

Dr.Jacob Joseph, Harward Medical School, USA

Dr.Ujwala Salvi, Nucleon Therapeutics, India

Dr.Omer, Sanofi, Canada

Dr.Ashok, Clinfomatrix, USA

Other Speakers

Mr.Chi Chen, E&Y, China 

Dr.Meenal Patwardhan, Abbvie, USA

Mr.Rajiv Joshi, E&Y, India

Keynote (Day 2)

Dr.Essam, Celyad, Belgium

Dr.Carole, Sun Pharma, Japan

Mr.Robert, Accenture, Spain

Session Speakers:

Mr.Ravish Kumar, Salzman Group, Australia

Dr.Abdeen, Ministry of health, UK.

Dr.Ripal Gharia, Cliantha research, India

Mr.Mohammed Gayoor khan,NFPS,Malaysia

Participating Companies:

·         Abbvie,USA

·         E&Y, China

·         Salmanz Group, Australia

·         Nucleon Therapetics, India

·         Saudi Patient safety Center, Saudi

·         AlphaBeta Pharma, UK

·         King Abdullah Medical City (KAMC)

·         Takeda, USA

Conference Announcement-Global Pharmacovigilance 2019

Greetings of the day,

This year is shaping up to be another exciting one for the Pharmacovigilance conference team. With nearly 30 Speakers already booked for the year, our thought leaders are looking forward to learning, networking, and presenting their work at a host of the event.

Here is a sampling of our first quarter of the conference. We hope to see you in person very soon!!!!

For more details visit: https://bit.ly/2HwRNwR

Collaboration:

NFPS-National Forum of Pharmacy students

Media Partners:

BioBased Press

Tabeeby

Japan Attractions

Conference Locate

Placidway

Keynote Speakers:

Dr.Jacob Joseph, USA

Dr.Ashok Srivastava, USA

Conference Announcement-Global Pharmacovigilance 2019

We are happy to announce Almac's Group as Exhibitor at the upcoming “12th Global Pharmacovigilance & Clinical Trials Summit” ( Global Pharmacovigilance 2018) on July 16-17, 2018

Hurry up!! Slots are Limited!! Join us as a Speaker/ Delegate.

To register : https://globalpharmacovigilance.pharmaceuticalconferences.com/registration.php

For Queries E: globalpharmacovigilance123@gmail.com

Join us! 12th Global Pharmacovigilance & Clinical Trials Summit | Few days ahead!! As we are few days away from 12th Global Pharmacovigilance & Clinical Trials Summit happening on July 16-17, 2018 in Sydney, Australia.

Venue: Mercure Sydney, 818-820 George St, Sydney NSW 2007, Australia


GlobalPharmacovigilance2018 would lay a platform for the interaction between experts around the world and aims in accelerating scientific discovery.

http://globalpharmacovigilance.pharmaceuticalconferences.com/registration.php

Expertise in Drug Discovery, Chemistry, Pre-Clinical Development, Clinicalresearch and Drugdevelopment, #Pharmacology and Pharmaceutics, Pharmacovigilance, Risk Management and Drugsafety, Clinicaloutcomes, Adverseevent Reporting System, Pharmacovigilance and its scope, Regulatory Safety Updates, Difficulties in Pre and Post marketing Surveillance, Biosimilars and Biologistics. and many more can share your research and listen to the expertise in the same field.


Email: globalpharmacovigilance123@gmail.com

globalpharmacovigilance@conferenceseries.net

#GroupDiscount!

https://globalpharmacovigilance.pharmaceuticalconferences.com/registration.php

Email globalpharmacovigilance123@gmail.com for details!

Participants interested to #register in group of 3 and more for #Globalpharmacovigilance2018 can contact us to avail #discounted prices.

Researchers in #pharmacovigilance, #clinical trials, #biosimilars, #regulatoryaffairs, #drug safety, #epidemiology, #Pharmacology, #toxicology #clinicalresearch can actively take part in 12th Global Pharmacovigilance & Clinical Trials Summit | July 16-17, 2018 Sydney, Australia